Papillomavirus Vaccines
Conditions
Brief summary
Vaccine uptake in the United States is lower in rural areas, especially for HPV vaccine. Reminder/recall has been identified as an effective strategy to increase vaccination rates. This study will assess the impact by rurality of vaccine reminder notices sent via the parent's preferred method of communication on HPV vaccination among 12 year-old patients in a regional healthcare system.
Interventions
Parents of 12 year-old patients due for ≥1 adolescent vaccine will receive a vaccine reminder notice every other month via their preferred method of communication (text message, email, mailed letter) until the adolescent receives all recommended vaccines, opts out of reminders, or turns 13.
Parents of 12 year-old patients due for ≥1 adolescent vaccine will receive a mailed vaccine reminder letter every other month until the adolescent receives all recommended vaccines, opts out of reminders, or turns 13.
Sponsors
Study design
Eligibility
Inclusion criteria
* Marshfield Clinic Health System patient aged 12 years with at least one preventive visit or two evaluation & management visits with a Marshfield Clinic Health System provider in the last 36 months * Due for at least one adolescent vaccine (HPV, MenACWY, Tdap)
Exclusion criteria
* Primary care provider is not affiliated with Marshfield Clinic Health System * Opted out of Marshfield Clinic Health System vaccine reminder notifications * Missing or invalid contact information * Deceased
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of patients that received 1 dose of HPV vaccine during follow-up based on electronic health data | 90 days | Receipt of 1 dose of HPV vaccine within 90 days of receipt of reminder (yes/no) will be assessed using vaccination data available from the Marshfield Clinic Health System electronic health record, which includes vaccinations administered outside of MCHS through data exchanges with the Wisconsin Immunization Registry. Specifically patients will be classified as having received 1 dose of HPV vaccine if they have record of receipt of HPV vaccine with a vaccination date during the 90-day follow-up period. |
Countries
United States